Altermune Technologies

Altermune Technologies develops therapeutics to combat resistant pathogens such as MRSA, C. difficile, pseudomonas, and pandemic influenza.

Altermune Technologies LLC, a newly formed company focused on the development of novel therapeutics to combat resistant pathogens such as MRSA, C. difficile, pseudomonas, and pandemic influenza. The company is led by a team of in-house scientists, and a wide network of partnerships, including collaborative research arrangements with a number of universities in the USA and Europe and corporate relationships with companies in oligonucleotide synthesis and aptamer selection.